These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23148608)

  • 1. Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.
    Ratcliffe MJ; Dougall IG
    BMC Pharmacol Toxicol; 2012 Nov; 13():15. PubMed ID: 23148608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
    J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
    Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
    Higham A; Lea S; Ray D; Singh D
    J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Lea S; Harbron C; Khan N; Booth G; Armstrong J; Singh D
    Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
    Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
    Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.
    Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW
    Immunobiology; 2013 Apr; 218(4):435-42. PubMed ID: 22727776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide.
    Triggiani M; Granata F; Petraroli A; Loffredo S; Frattini A; Staiano RI; Monaco G; Marone G
    Int Arch Allergy Immunol; 2009; 150(2):144-55. PubMed ID: 19439980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
    Kent LM; Smyth LJ; Plumb J; Clayton CL; Fox SM; Ray DW; Farrow SN; Singh D
    J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
    Yasui H; Hideshima T; Ikeda H; Jin J; Ocio EM; Kiziltepe T; Okawa Y; Vallet S; Podar K; Ishitsuka K; Richardson PG; Pargellis C; Moss N; Raje N; Anderson KC
    Br J Haematol; 2007 Feb; 136(3):414-23. PubMed ID: 17173546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages.
    Ek A; Larsson K; Siljerud S; Palmberg L
    Allergy; 1999 Jul; 54(7):691-9. PubMed ID: 10442524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation.
    Charron CE; Russell P; Ito K; Lea S; Kizawa Y; Brindley C; Singh D
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29074542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophilic inflammatory activity of ASP3258, a novel phosphodiesterase type 4 inhibitor.
    Kubo S; Kobayashi M; Iwata M; Miyata K; Takahashi K; Shimizu Y
    Int Immunopharmacol; 2012 Jan; 12(1):59-63. PubMed ID: 22041526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
    Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
    Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
    Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
    J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
    Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
    J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro.
    Singh RK; Diwan M; Dastidar SG; Najmi AK
    Hum Exp Toxicol; 2018 May; 37(5):521-531. PubMed ID: 28629242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages.
    Trotta V; Lee WH; Loo CY; Young PM; Traini D; Scalia S
    Eur J Pharm Sci; 2016 Apr; 86():20-8. PubMed ID: 26944422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.